eff Cancer Research Results
eff, efficacy: Click to Expand ⟱
| Source: |
| Type: |
Power to enhance an anti cancer effect
|
Bladder, Bladder Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
tumCV↓, eff↓, Apoptosis↑, Casp3↑, ROS↑, Cyt‑c↑, MMP↓, Bcl-2↓, BAX↑, MOMP↑, TumCG↓,
cl‑Casp3↑, cl‑Casp8↑, cl‑Casp9↑, cl‑PARP↑, ROS↑, MMP↓, DNAdam↑, eff↓,
| - |
in-vitro, |
Bladder, |
5637 |
|
|
|
TumCG↓, Apoptosis↑, IAP1↓, IAP2↓, Casp3↑, Casp9↑, BAX↑, Bcl-2↓, MMP↓, Casp8↑, BID↑, ROS?, eff↓, DR4↑, DR5↑, FasL↑, TRAIL↑,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
tumCV↓, TumCP↓, TumCMig↓, Casp↑, TumAuto↑, LC3B-II↑, p‑AMPK↑, mTOR↓, BMI1↓, ROS↑, eff↓,
| - |
in-vitro, |
CRC, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Nor, |
SV-HUC-1 |
|
|
|
- |
in-vitro, |
Bladder, |
5637 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
HDAC↓, AntiTum↑, TumCMig↓, AMPK↑, mTOR↑, TumAuto↑, ROS↑, miR-139-5p↑, BMI1↓, TumCI?, E-cadherin↑, N-cadherin↓, Vim↓, Snail↓, cl‑PARP↑, cl‑Casp3↑, BAX↑, Bcl-2↓, Bcl-xL↓, MMP↓, PINK1↑, PARK2↑, TumMeta↓, TumCG↓, LC3II↑, p62↓, eff↓,
| - |
in-vivo, |
RCC, |
A498 |
|
|
|
- |
in-vitro, |
RCC, |
T24/HTB-9 |
|
|
|
- |
NA, |
Bladder, |
5637 |
|
|
|
TRPV1↑, TumCP↓, Casp↑, Apoptosis↑, SIRT1↓, MMP2↓, MMP9↓, TumCMig↓, TumCCA↑, ROS↑, DNAdam↑, PD-L1↑, eff↓,
eff↑, Apoptosis↑, Casp↑, MMP↓, BID↑, DR5↑, ROS↑, NRF2↑, eff↑, eff↓,
| - |
in-vitro, |
Bladder, |
5637 |
|
|
|
tumCV↓, CycB/CCNB1↑, p‑CDK1↑, Apoptosis↑, Casp8↑, Casp9↑, Casp3↑, cl‑PARP↑, ROS↑, eff↓,
HDAC↓, eff↓, TumW↓, TumW↓, angioG↓, *toxicity↓, GutMicro↝, AntiCan↑, ROS↑, MMP↓, Cyt‑c↑, Bax:Bcl2↑, Casp3↑, Casp9↑, Casp8∅, cl‑PARP↑, TRAIL↑, DR5↑, eff↓, NRF2↑, ER Stress↑, COX2↓, EGFR↓, HER2/EBBR2↓, ChemoSen↑, NF-kB↓, TumCCA?, p‑Akt↓, p‑mTOR↓, p70S6↓, p19↑, P21↑, CD44↓, CSCs↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
tumCV↓, Apoptosis↑, Cyt‑c↑, Bax:Bcl2↑, Casp9↑, Casp3↑, Casp8∅, cl‑PARP↑, ROS↑, MMP↓, eff↓, ER Stress↑, p‑NRF2↑, HO-1↑,
| - |
in-vitro, |
Bladder, |
5637 |
|
|
|
- |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
tumCV↓, TumCP↓, TumCI↓, Casp↑, ROS↑, PD-L1↓, EMT↓, MMP↓, eff↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Bladder, |
J82 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
- |
in-vitro, |
Nor, |
L02 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
MMP↓, Cyt‑c↑, Casp3↑, p‑JNK↑, p‑p38↑, ROS↑, eff↓, tumCV↓, selectivity↑, *toxicity↓, TumVol↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Bladder, |
J82 |
|
|
|
Glycolysis↑, GlucoseCon↑, lactateProd↑, TCA↓, PI3K↑, Akt↑, AMPK↑, mTORC1↓, TumAuto↑, GLUT1↑, HK2↑, LDHA↑, ACC↓, PDH↓, eff↓, cMyc↓, Hif1a↑, p‑Akt↑, eff↓, eff↓, eff↓, eff↓, ROS↑,
Showing Research Papers: 1 to 13 of 13
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 13
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
HO-1↑, 1, NRF2↑, 2, p‑NRF2↑, 1, PARK2↑, 1, ROS?, 1, ROS↑, 12,
Mitochondria & Bioenergetics ⓘ
MMP↓, 9, PINK1↑, 1,
Core Metabolism/Glycolysis ⓘ
ACC↓, 1, AMPK↑, 2, p‑AMPK↑, 1, cMyc↓, 1, GlucoseCon↑, 1, Glycolysis↑, 1, HK2↑, 1, lactateProd↑, 1, LDHA↑, 1, PDH↓, 1, SIRT1↓, 1, TCA↓, 1,
Cell Death ⓘ
Akt↑, 1, p‑Akt↓, 1, p‑Akt↑, 1, Apoptosis↑, 6, BAX↑, 3, Bax:Bcl2↑, 2, Bcl-2↓, 3, Bcl-xL↓, 1, BID↑, 2, Casp↑, 4, Casp3↑, 6, cl‑Casp3↑, 2, Casp8↑, 2, Casp8∅, 2, cl‑Casp8↑, 1, Casp9↑, 4, cl‑Casp9↑, 1, Cyt‑c↑, 4, DR4↑, 1, DR5↑, 3, FasL↑, 1, IAP1↓, 1, IAP2↓, 1, p‑JNK↑, 1, MOMP↑, 1, p‑p38↑, 1, TRAIL↑, 2, TRPV1↑, 1,
Kinase & Signal Transduction ⓘ
HER2/EBBR2↓, 1, p70S6↓, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 6,
Protein Folding & ER Stress ⓘ
ER Stress↑, 2,
Autophagy & Lysosomes ⓘ
LC3B-II↑, 1, LC3II↑, 1, p62↓, 1, TumAuto↑, 3,
DNA Damage & Repair ⓘ
DNAdam↑, 2, cl‑PARP↑, 5,
Cell Cycle & Senescence ⓘ
p‑CDK1↑, 1, CycB/CCNB1↑, 1, p19↑, 1, P21↑, 1, TumCCA?, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
BMI1↓, 2, CD44↓, 1, CSCs↓, 1, EMT↓, 1, HDAC↓, 2, mTOR↓, 1, mTOR↑, 1, p‑mTOR↓, 1, mTORC1↓, 1, PI3K↑, 1, TumCG↓, 3,
Migration ⓘ
E-cadherin↑, 1, miR-139-5p↑, 1, MMP2↓, 1, MMP9↓, 1, N-cadherin↓, 1, Snail↓, 1, TumCI?, 1, TumCI↓, 1, TumCMig↓, 3, TumCP↓, 3, TumMeta↓, 1, Vim↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, EGFR↓, 1, Hif1a↑, 1,
Barriers & Transport ⓘ
GLUT1↑, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, NF-kB↓, 1, PD-L1↓, 1, PD-L1↑, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, eff↓, 18, eff↑, 2, selectivity↑, 1,
Clinical Biomarkers ⓘ
EGFR↓, 1, GutMicro↝, 1, HER2/EBBR2↓, 1, PD-L1↓, 1, PD-L1↑, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, AntiTum↑, 1, TumVol↓, 1, TumW↓, 2,
Total Targets: 108
Pathway results for Effect on Normal Cells:
Functional Outcomes ⓘ
toxicity↓, 2,
Total Targets: 1
Scientific Paper Hit Count for: eff, efficacy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:32 Cells:% prod#:% Target#:961 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page